Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dian Daniella1

Efficacy of Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor as First-Line and Second-Line Treatment for Helicobacter Pylori Eradication

Open Journal of Gastroenterology and Hepatology
2019English

Related publications

Proton Pump Inhibitor-Amoxicillin-Clarithromycin Versus Proton Pump Inhibitor-Amoxicillin-Metronidazole as First-Line Helicobacter Pylori Eradication Therapy

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2012English

Efficacy of Short-Term Triple Therapy With Amoxicillin, Clarithromycin and Proton Pump Inhibitor for Eradication of Helicobacter Pylori

Progress of Digestive Endoscopy(1972)
1998English

Letter: A Potassium-Competitive Acid Blocker vs a Proton Pump Inhibitor for Healing Endoscopic Submucosal Dissection-Induced Artificial Ulcers After Treatment of Gastric Neoplasms-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Lactobacillus Reuteri – An Alternative in the First-Line of Helicobacter Pylori Eradication

Farmacia
ToxicologyPharmaceuticsPharmacology
2019English

First-Line Helicobacter Pylori Eradication in Patients With Chronic Kidney Diseases in Taiwan

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

14 Day-Sequential, Concomitant, and Hybrid Therapies for First-Line Helicobacter Pylori (H. PYLORI) Eradication: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Levofloxacin-Based Triple Therapy vs. Quadruple Therapy in Second-Line Helicobacter Pylori Treatment: A Randomized Trial

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2003English

Clinical Efficacy of Gemifloxacin-Containing Triple Therapy for First-Line Treatment of Helicobacter Pylori Infection: A Pilot Study

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2017English

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy